Method of detecting schizophrenia risk
First Claim
Patent Images
1. A method of determining the susceptibility of a patient to a neuropsychiatric disorder comprising:
- (a) obtaining a sample from a patient; and
(b) testing the sample for the presence of a polymorphism in the Nogo gene, wherein the presence of a polymorphism indicates that the patient is susceptible to a neuropsychiatric disorder.
0 Assignments
0 Petitions
Accused Products
Abstract
Methods and kits for determining susceptibility of a patient to neuropsychiatric disorders are described. The method involves analyzing a sample comprising nucleic acids from a patient for a polymorphism of the Nogo gene.
-
Citations
19 Claims
-
1. A method of determining the susceptibility of a patient to a neuropsychiatric disorder comprising:
-
(a) obtaining a sample from a patient; and
(b) testing the sample for the presence of a polymorphism in the Nogo gene, wherein the presence of a polymorphism indicates that the patient is susceptible to a neuropsychiatric disorder. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 13, 14, 15)
-
- 9. A method of diagnosing a neuropsychiatric disorder in a patient by analyzing for a presence of a polymorphism in the Nogo gene in a biological sample obtained from the patient, wherein the presence of a polymorphism in the Nogo gene, indicates a likelihood that the patient is suffering from a neuropsychiatric disorder.
- 11. A method of determining if a patient will have increased symptomatology associated with a neuropsychiatric disorder by analyzing for a presence of a polymorphism in the Nogo gene in a biological sample obtained from the patient, wherein the presence of a polymorphism in the Nogo gene, indicates a likelihood that the patient will have increased symptomatology associated with a neuropsychiatric disorder.
Specification